Hot News

December 8,2008
CeMines Licenses Lung Cancer IP to Ortho Clinical Diagnostic.

August 21, 2008
CeMines extends licensing partnership with Millipore for all antibody products

July, 2008
"Use of novel autoantibody and cancer-related protein arrays for the detection of esophageal adenocarcinoma in serum” published in The Journal of Thoracic and Cardiovascular Surgery(2008, 136:199-204) by Kilic, A., et.al. describing the promising approach of CeMines approach to early detection of esophageal cancer.

Press Room


December 8, 2008

CeMines Licenses Lung Cancer IP to Ortho Clinical Diagnostics

August 21, 2008

CeMines extends licensing partnership with Millipore for all antibody products

July, 2008

"Use of novel autoantibody and cancer-related protein arrays for the detection of esophageal adenocarcinoma in serum” published in The Journal of Thoracic and Cardiovascular Surgery(2008, 136:199-204) by Kilic, A., et.al. describing the promising approach of CeMines approach to early detection of esophageal cancer.

January, 2006

CeMines restructures to focus on developing its’ core IP regarding Cancer Diagnostics

July 3, 2005

CeMines presents lung cancer test results at the World Biomarker Congress 2005

February 24, 2005

CeMines presents its’ molecular fingerprinting concept at AACR

October 30, 2004

CeMines enters into marketing and sales agreement with Chemicon International to sell CeMines antibodies

October 15, 2003

CeMines enters into marketing and sales agreement with Sigma Aldrich to sell CeMines antibodies